Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice

被引:97
作者
Dai, CS [1 ]
Yang, JW [1 ]
Bastacky, S [1 ]
Xia, JL [1 ]
Li, YJ [1 ]
Liu, YH [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2004年 / 15卷 / 10期
关键词
D O I
10.1097/01.ASN.0000139479.09658.EE
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy is characterized by progressive loss of renal function, persistent proteinuria, and relentless accumulation of extracellular matrix leading to glomerulosclerosis and interstitial fibrosis. This study investigated the potential effects of long-term expression of exogenous hepatocyte growth factor (HGF) on normal and diabetic kidneys. Intravenous injection of human HGF gene via naked plasmid vector resulted in abundant HGF protein specifically localized in renal glomeruli, despite an extremely low level of transgene mRNA in the kidney. In uninephrectomized mice made diabetic with streptozotocin, delivery of exogenous HGF gene ameliorated the progression of diabetic nephropathy. HGF attenuated urine albumin and total protein excretion in diabetic mice. Exogenous HGF also mitigated glomerular mesangial expansion, reduced fibronectin and type I collagen deposition, and prevented interstitial myofibroblast activation. In addition, HGF prevented kidney cells from apoptotic death in the glomeruli and tubulointerstitium. Moreover, expression of HGF inhibited renal expression of TGF-beta1 and reduced urine level of TGF-beta1 protein. Therefore, despite the effects of HGF on diabetic nephropathy being controversial, these observations suggest that supplementation of HGF is beneficial in ameliorating diabetic renal insufficiency in mice.
引用
收藏
页码:2637 / +
页数:12
相关论文
共 53 条
[11]  
Dai CS, 2002, J AM SOC NEPHROL, V13, P411, DOI 10.1681/ASN.V132411
[12]   Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats with established renal injury [J].
Dworkin, LD ;
Gong, RJ ;
Tolbert, E ;
Centracchio, J ;
Yano, N ;
Zanabli, AR ;
Esparza, A ;
Rifai, A .
KIDNEY INTERNATIONAL, 2004, 65 (02) :409-419
[13]   Prevention of acute ischemic renal failure by targeted delivery of growth factors to the proximal tubule in transgenic mice:: The efficacy of parathyroid hormone-related protein and hepatocyte growth factor [J].
Fiaschi-Taesch, NM ;
Santos, S ;
Reddy, V ;
Van Why, SK ;
Philbrick, WF ;
Ortega, A ;
Esbrit, P ;
Orloff, JJ ;
Garcia-Ocaña, A .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (01) :112-125
[14]   Reversibility of glucose-induced changes in mesangial cell extracellular matrix depends on the genetic background [J].
Fornoni, A ;
Striker, LJ ;
Zheng, F ;
Striker, GE .
DIABETES, 2002, 51 (02) :499-505
[15]   Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis [J].
Fornoni, A ;
Li, H ;
Foschi, A ;
Striker, GE ;
Striker, LJ .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (01) :275-280
[16]   Renal effects of antihypertensive therapy in uninephrectomized diabetic rats [J].
Gallego, B ;
Flores, O ;
Lopez-Novoa, JM ;
Perez-Barriocanal, F .
RESEARCH IN EXPERIMENTAL MEDICINE, 1997, 197 (04) :199-209
[17]  
Gao XJ, 2002, KIDNEY INT, V62, P1238
[18]   Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death [J].
García-Ocaña, A ;
Takane, KK ;
Reddy, VT ;
Lopez-Talavera, JC ;
Vasavada, RC ;
Stewart, AF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (01) :343-351
[19]   Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia [J].
Garcia-Ocaña, A ;
Takane, KK ;
Syed, MA ;
Philbrick, WM ;
Vasavada, RC ;
Stewart, AF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) :1226-1232
[20]  
Goldfarb S, 2001, Trans Am Clin Climatol Assoc, V112, P27